InVivoMab anti-mouse ICOS

Catalog number: BE0059_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 3131.00
Expected delivery time: 7 days

Product specifications for - InVivoMab anti-mouse ICOS

Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Product group: Antibodies
Category: Primary Antibodies
Application: Flow Cytometry; Neutralisation/Blocking
Host: Rat
Clonality: Monoclonal
Isotype: IgG2b Kappa
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: 7E.17G9
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG2b isotype control (BE0090)
Recommended Dilution Buffer: InVivoPure pH 8.0 Dilution Buffer (IP0080)
Additional information: 
Synonyms: 7E.17G9; BE0059; ICOS; CVID1; CD278; AILIM; inducible costimulator; inducible T-cell costimulator; activation-inducible lymphocyte immunomediatory molecule; inducible T-cell co-stimulator; BioXCell
Villegas-mendez A, Shaw TN, Inkson CA, Strangward P, De souza JB, Couper KN. Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection. Infect Immun. 2016;84(1):34-46. Read more
Krupnick AS, Lin X, Li W, et al. Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J Clin Invest. 2014;124(3):1130-43. Read more
Rabant M, Gorbacheva V, Fan R, Yu H, Valujskikh A. CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity. Am J Transplant. 2013;13(11):2831-2841. Read more
Charbonnier LM, Vokaer B, Lemaître PH, Field KA, Leo O, Le moine A. CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Am J Transplant. 2012;12(9):2313-21. Read more
Kadri N, Korpos E, Gupta S, et al. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. J Immunol. 2012;188(7):3138-49. Read more